Mark Rus

Mark Rus

Company: Delix Therapeutics

Job title: Chief Executive Officer


Roundtable Discussion: The Steps to Commercial Success – Where Shall We Tread? 11:45 am

An interactive session to allow collaborative discourse between industry leaders and decision makers to set actionable targets for business development in the field of psychedelics and beyond. Contemplating the commercially viable psychedelic model to strengthen business outcomes Optioning optimal service development for efficient scalability to maximize delivery to patients • Identifying the intellectual property challenges…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.